Integrated Filing — IndAS

General information about company
Scrip Code	532663
NSE Symbol	SASKEN
MSEI Symbol	NOTLISTED
ISIN	INE231F01020
Name of company	Sasken Technologies Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	25-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	18-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Software services
Start date and time of board meeting	25-Apr-2025   09:00:00
End date and time of board meeting	25-Apr-2025   19:00:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-01-24
Indicate Company website link for updated RPT policy of the Company	https://www.sasken.com/investors/corporate-governance
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1144338000	4458243000
	Other income	156551000	619654000
	Total income	1300889000	5077897000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	956559000	3624158000
(e)	Finance costs	4995000	18211000
(f)	Depreciation, depletion and amortisation expense	27643000	107715000
(f)	Other Expenses
1	Other Expenses	200368000	746831000
	Total other expenses	200368000	746831000
	Total expenses	1189565000	4496915000
3	Total profit before exceptional items and tax	111324000	580982000
4	Exceptional items	0	0
5	Total profit before tax	111324000	580982000
6	Tax expense
7	Current tax	22933000	98244000
8	Deferred tax	-26030000	-4762000
9	Total tax expenses	-3097000	93482000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	114421000	487500000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	114421000	487500000
17	Other comprehensive income net of taxes	-25732000	21953000
18	Total Comprehensive Income for the period	88689000	509453000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	151216000	151216000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		0
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	7.57	32.29
	Diluted earnings (loss) per share from continuing operations	7.52	32.03
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	7.57	32.29
	Diluted earnings (loss) per share from continuing and discontinued operations	7.52	32.03
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Other Equity as at year ended March 31, 2025 - INR 77436.61. n nNOTES: n n1. The above audited standalone financial results for the quarter and year ended March 31, 2025 (“standalone results”), have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) as prescribed under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 (as amended) n nThe figures for the quarters ended March 31, 2025 and March 31, 2024 are the balancing figures between the audited figures in respect of the full financial years and published audited year to date figures upto the end of the third quarter of the relevant financial year. n n2. The standalone results have been approved by the Board of Directors of the Company at its meeting held on April 25, 2025 and the undersigned is duly authorized to sign the same. The statutory auditors have expressed an unmodified opinion on these standalone results. n n3. Segment Reporting n nThe Chief Executive Officer of the Company has been identified as the Chief Operating Decision Maker (CODM) as defined by Ind AS 108, “Operating Segments”. The Company operates in one segment only i.e. “Software Services”. The CODM evaluates performance of the Company based on revenue and operating income from “Software Services”. Accordingly, segment information has not been separately disclosed. n n4. Sasken Design Solutions Pte. Ltd, a wholly owned subsidiary of the Company with its registered office in Singapore, acquired 100% share capital of the BORQS International Holding Corp along with its identified wholly owned subsidiaries for an aggregate consideration (including earn-outs) not exceeding US$ 40 million (up to ~Rs.338 crores) subject to adjustments / completion of specified conditions, as set out in the Share Purchase Agreement dated April 8, 2025. Following this acquisition, the said target entities will become Step Down Subsidiaries (SDS) of the Company effective April 8, 2025. n nAs the acquisition occurred after the reporting date of March 31, 2025, and does not relate to conditions existing at that date, no adjustments have been made in the financial statements for the year ended March 31, 2025. The accounting for the business combination will be completed in the financial statements for the year ending March 31, 2026, in accordance with Ind AS 103 – Business Combinations. The initial assessment of the fair values of the assets acquired and liabilities assumed is in progress as at the date of approval of these financial statements. n n5. The Board of Directors has recommended a final dividend of Rs.13 per equity share of Rs. 10 each for the year ended March 31, 2025. The payment is subject to approval of shareholders in the ensuing Annual General Meeting of the Company. Once approved, the cumulative dividend for the year will amount to Rs. 25 per equity share (including interim dividend of Rs.12 declared on October 25, 2024). n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	514402000
	Capital work-in-progress	5757000
	Investment property	0
	Goodwill	0
	Other intangible assets	622000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	4272855000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	83798000
	Total non-current financial assets	4356653000
	Deferred tax assets (net)	717772000
	Other non-current assets	0
	Total non-current assets	5595206000
2	Current assets
	Inventories	0
	Current financial asset
	Current investments	1940501000
	Trade receivables, current	929532000
	Cash and cash equivalents	142525000
	Bank balance other than cash and cash equivalents	3077000
	Loans, current	0
	Other current financial assets	435959000
	Total current financial assets	3451594000
	Current tax assets (net)
	Other current assets	127086000
	Total current assets	3578680000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	9173886000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	151216000
	Other equity	7743661000
	Total equity attributable to owners of parent	7894877000
	Non controlling interest
	Total equity	7894877000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	155916000
	Total non-current financial liabilities	155916000
	Provisions, non-current	91047000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	246963000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	4139000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	145259000
	Total Trade payable	149398000
	Other current financial liabilities	220455000
	Total current financial liabilities	369853000
	Other current liabilities	294758000
	Provisions, current	155790000
	Current tax liabilities (Net)	211645000
	Deferred government grants, Current	0
	Total current liabilities	1032046000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	1279009000
	Total equity and liabilites	9173886000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement of defined benefit plans	-28958000	-2739000
2	Equity instruments through other comprehensive income	4419000	13033000
	Total Amount of items that will not be reclassified to profit and loss	-24539000	10294000
2	Income tax relating to items that will not be reclassified to profit or loss	-6247000	2316000
3	Amount of items that will be reclassified to profit and loss
1	Effective portion of gain / (loss) on hedging instruments in cash flow	-1832000	-15970000
2	Debt instruments through other comprehensive income	-8374000	26217000
	Total Amount of items that will be reclassified to profit and loss	-10206000	10247000
4	Income tax relating to items that will be reclassified to profit or loss	-2766000	-3728000
5	Total Other comprehensive income	-25732000	21953000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			580982000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			18211000
	Adjustments for decrease (increase) in inventories			0
	Adjustments for decrease (increase) in trade receivables, current			-508947000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			-313173000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-132574000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			107715000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			96346000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			65000
	Adjustments for dividend income			106500000
	Adjustments for interest income			171911000
	Adjustments for share-based payments			38026000
	Adjustments for fair value losses (gains)			-339394000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-517000
	Other adjustments to reconcile profit (loss)			-521000
	Other adjustments for non-cash items			-139000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-1313313000
	Net cash flows from (used in) operations			-732331000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			-14361000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			-717970000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			92896000
	Other cash receipts from sales of equity or debt instruments of other entities			5539950000
	Other cash payments to acquire equity or debt instruments of other entities			4433811000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			1218000
	Purchase of property, plant and equipment			69517000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			106500000
	Interest received			142304000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-41000
	Net cash flows from (used in) investing activities	1193707000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			436000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			0
	Payments of lease liabilities			71254000
	Dividends paid			377289000
	Interest paid			0
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-448107000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			27630000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			-65000
	Net increase (decrease) in cash and cash equivalents			27565000
	Cash and cash equivalents cash flow statement at beginning of period			114960000
	Cash and cash equivalents cash flow statement at end of period			142525000